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515 Biobanks with Over 60 Million Biological Samples
Petr Holub,1 Morris Swertz,1,2 Robert Reihs,1,3 David van Enckevort,1,2
Heimo Mu¨ller,1,3 and Jan-Eric Litton1
B iobanks
1 are well-organized repositories of bio-
logical material. They have become the fundamental
resource for advancing medical research and constitute
a major component of more generally understood bio-
resources. Yet they face a number of challenges to become
more utilized on the national and global scale. These chal-
lenges range from fragmentation of data structure and
sometimes even lack of availability of data,2–4 lack of
consistent quality management and traceability5–8 to frag-
mentation of privacy protection regulations9–13 and techni-
cal, organizational, and legal aspects of scalable secure
storage and processing of privacy-sensitive big data.14–16 To
address the fragmentation and findability aspects, BBMRI-
ERIC has released its Directory as a first IT service,
providing aggregate information about the biobanks and
bioresources. The Directory features a novel scalable dis-
tributed architecture, which enables updating data about
changing resources in a long-term sustainable manner.
Inventory data about the bioresources, describing avail-
ability of various resource types such as biological material,
data, expertise, and offered services, are the basis for any
further interaction between the biobanks as resource/service
providers and their users or collaborators. There have been
various terms used for these types of services, including
‘‘catalogs’’ and ‘‘registries.’’ Inventory data cover various
types of information that is not considered privacy sensitive
and thus shareable in an open-access mode. The business
model of a bioresource may impose access restrictions,
however. From the users’ perspective, it is important to
achieve consistent or at least algorithmically harmonizable
semantics of the information, so that it is possible to im-
plement efficient search or filtering services.
There have been a number of attempts to improve the
situation with availability and consistency of the inventory
data in the past decade both internationally and nation-
ally. Prominent international examples include P3G Ob-
servatory,17 BBMRI Preparatory Phase Catalogue,3 ISBER
International Resource Locator,18 Maelstrom Repository,19
BBMRI-LPC catalogs,20,21 or RD-CONNECT Catalogue22,23
and the NIH/NCATS GRDR24 on rare diseases. Although
being very valuable for helping to organize biobanking and
bioresources in projects with limited life spans, these tools
also demonstrate the key deficiency of such centrally built
and managed systems: because of the lack of automated data
updates, the information becomes sooner or later obsolete
and thus of limited use for the users.
In contrast, distributed information systems are well known
in computer infrastructures, such as cloud and grid computing
systems,25 where various architectures have been explored,
ranging from client-server communication schemes26,27 to
peer-to-peer systems.28–30 The biobanking community needs
to learn from these endeavors and take a similar approach with
(a) distributed architecture that allows for information flow
from the original sources to the inventory services, (b) well-
defined stable application programming interfaces (APIs) that
allow for their implementation in the biobank information
management systems, (c) clear component-based architec-
ture that allows for simple implementation of relevant data
extraction and harmonization components as close to the
original information sources as possible to include in-depth
knowledge of the data.
BBMRI-ERIC Directory
BBMRI-ERIC, the Biobanking and BioMolecular Re-
sources Research Infrastructure-European Research Infra-
structure Consortium, is a new form of legal organization for
biobanking in Europe. BBMRI-ERIC has started to develop
the BBMRI-ERIC Directory as its first information technol-
ogy tool. Directory 1.0 was released in July 2015 with basic
support for biobanks, and Directory 2.0 was released in
December 2015, supporting biobanks, collections, and
biobank networks. The BBMRI-ERIC Directory has been
designed with the following two primary use cases in mind:
biomedical and bioinformatics researchers seeking re-
trieval of samples/data, or for collecting/hosting services
for their samples/data; biobank operators needing to iden-
tify similar biobanks (experience sharing, collaboration,
etc.) and to promote their visibility. One can also imagine
other use cases such as research participants (donors/
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patients) and their organizations interested in determining
where their samples might be located, the purposes they are
being used, and for funding and governance bodies looking
into the extent and use statistics of funded infrastructures.
The first development step was designing an extensible
data model, which covers all three key components of
biobanks: (a) biological material and associated physical
storage facilities, (b) data and associated data storage
facilities, and (c) expertise of the biobankers. The core of
the data model for Directory 2.0 relies on MIABIS 2.0,31
which is the evolution of the previously published MIABIS
model.32 The Directory’s data model includes biobanks as
institutional units hosting collections of samples and data,
as well as biobank networks used to further aggregate
biobanks or their collections. Our current data model is
highly aggregated and serves to primarily identify candi-
date biobanks that might have samples for the given pur-
pose or biobanks that provide relevant services.
From the architectural perspective, the Directory is a
distributed system using multilayer architecture as shown in
Figure 1. Each layer uses clearly defined machine-readable
APIs (LDAP, REST/JSON) and data formats, which enable
automated propagation of updates, allows for building purpose-
focused user interfaces, as well as integrates into larger auto-
mated workflows (e.g., currently developed BBMRI-ERIC
Negotiator to facilitate access negotiation). As for Directory
2.0, there are two web-based user interfaces implemented: the
main BBMRI-ERIC Directory interface33 and the BBMRI.nl
interface,34 integrating BBMRI-ERIC data using the Molgenis
platform.35
The current Directory 2.0 includes 515 biobanks and
standalone collections, with an estimated number of samples
exceeding 60,000,000. This covers 136 clinical or disease-
specific biobanks and 189 population biobanks, based on the
classification proposed in an article3 from the BBMRI Pre-
paratory Phase. This is a conservative estimate based on the
10n order of magnitude attribute, which is mandatory for each
collection in Directory 2.0, compared with optional exact
size. For the largest biobanks, the estimate has been adjusted
based on direct communication to avoid substantial bias. We
consider these estimates sufficient, as exact counting would
require consensus on sample and aliquot definition (expected
to be clarified by ISO TC 276 between 2017 and 2018).*
It should also be noted that the access to the samples/data
is controlled by the biobanks, which means biobanks may or
may not allow access depending on the types of requests
received by them. Based on Directory 2.0 data, *23% of
biobanks provide access to samples/data based on a fee
structure and*28% based on joint projects. Approximately
60% do not publish this information and need to be con-
tacted directly to receive information on access conditions.
Future Work
There are two basic directions to improve the inventory
services, and particularly the BBMRIERIC Directory. The
first direction is to improve specificity in the responses.
FIG. 1. Distributed and modular BBMRI-ERIC Directory architecture. It typically comprises online or offline data flow
from biobanks and other bioresources (not shown for sake of simplicity)/ aggregating nodes (e.g., BBMRI-ERIC national
nodes)/ central BBMRI-ERIC Directory/ user interfaces. Color images available online at www.liebertpub.com/bio
*We would advise against ‘‘abandoning samples’’ and using only
number of research participants (donors), as has already happened
in some Nordic population biobanks, because such an approach
does not allow differentiation between a biobank that collects one
sample per participant and a time-consistent series of samples per
participant.
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Although the biobanks are already urged to publish data that
are as accurate as possible, many issues will only be re-
solved once we help biobanks fully implement online in-
terfaces to their primary information systems. A particular
example is the list of available diagnoses, which is among
the most searched for parameters.36 Some biobanks do not
have this information themselves and must either retrieve it
using targeted questions to hospital information systems or
must resort to consulting external registries.
The second direction for the future extensions is improv-
ing coverage of various aspects of the biobanks, such as
availability of quality management systems, advertising ad-
ditional services such as sample/data hosting, or providing
semantic translation support for data that comes in different
coding or semantics from different sources. The Directory
service can also be used to map various types of identifiers
and to publish persistent identifiers for sample sets and da-
tasets once they are used for publishing, hence further sup-
porting efforts toward reproducible biomedical research.
These extensions are expected in Directory 3.0 (to be re-
leased in 2016) and onward. BBMRI-ERIC also works on
extending geographical coverage of the Directory by merg-
ing with the validated RD-CONNECT Catalogue data during
2016 (e.g., data from the United States and Australia).
Last but not least, the communication of many users with
many biobanks at the same time is not efficient, and tools for
simplifying such communication are needed. BBMRI-ERIC
will address these issues using the Negotiator tool integrated
with the Directory, intended for cumulative communication
between a user and multiple biobanks at the same time.
Because of its potential global impact, the Directory has
been proposed as a tool for organizing bioresources’ inven-
tory information as a part of the BBMRI-ERIC application
for the G7 Group of Senior Officials on Global Research
Infrastructures.
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